View Related Items
Category 6 - PATHOLOGY SERVICES
PN.7.14
Note for haematological malignancy gene panel tests
Testing should include, but not be restricted to, genes described in the current World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms or other appropriate international guidelines.
Related Items
Category 6 - PATHOLOGY SERVICES
73445 - Additional Information
Characterisation of a variant or variants in a panel of at least 25 genes using DNA and RNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of myeloid origin
Applicable once per diagnostic episode, at diagnosis, disease progression or relapse
Fee: $1,100.00 Benefit: 75% = $825.00 85% = $1,001.30
(See para PN.7.14 of explanatory notes to this Category)
Category 6 - PATHOLOGY SERVICES
73446 - Additional Information
Characterisation of a variant or variants in a panel of at least 25 genes using DNA and RNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of lymphoid origin
Applicable once per diagnostic episode, at diagnosis, disease progression or relapse
Fee: $1,100.00 Benefit: 75% = $825.00 85% = $1,001.30
(See para PN.7.14 of explanatory notes to this Category)
Category 6 - PATHOLOGY SERVICES
73447 - Additional Information
Characterisation of a variant or variants in a panel of at least 25 genes using DNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of myeloid origin
Applicable once per diagnostic episode, at diagnosis, disease progression or relapse
Fee: $927.90 Benefit: 75% = $695.95 85% = $829.20
(See para PN.7.14 of explanatory notes to this Category)
Category 6 - PATHOLOGY SERVICES
73448 - Additional Information
Characterisation of a variant or variants in a panel of at least 25 genes using DNA, requested by a specialist or consultant physician, to determine the diagnosis, prognosis and/or management of a patient presenting with a clinically suspected haematological malignancy of lymphoid origin
Applicable once per diagnostic episode, at diagnosis, disease progression or relapse
Fee: $927.90 Benefit: 75% = $695.95 85% = $829.20
(See para PN.7.14 of explanatory notes to this Category)
Legend
- Assist - Addition/Deletion of (Assist.)
- Amend - Amended Description
- Anaes - Anaesthetic Values Amended
- Emsn - EMSN Change
- Fee - Fee Amended
- Renum - Item Number Change (renumbered)
- New - New Item
- NewMin - New Item (previous Ministerial Determination)
- Qfe - QFE Change